BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1288 related articles for article (PubMed ID: 15967835)

  • 1. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
    Tserenpuntsag B; Kołacińska A; Jabłonowska E
    Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modern management of non-Hodgkin lymphoma in HIV-infected patients.
    Mounier N; Spina M; Gisselbrecht C
    Br J Haematol; 2007 Mar; 136(5):685-98. PubMed ID: 17229246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of acquired immunodeficiency syndrome malignancies.
    Goedert JJ
    Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives.
    Vanni T; Sprinz E; Machado MW; Santana Rde C; Fonseca BA; Schwartsmann G
    Cancer Treat Rev; 2006 Oct; 32(6):445-55. PubMed ID: 16860939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiology of HIV-associated malignancies].
    Launay O; Guillevin L
    Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
    Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
    Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatments of AIDS-related Kaposi's sarcoma.
    Aversa SM; Cattelan AM; Salvagno L; Crivellari G; Banna G; Trevenzoli M; Chiarion-Sileni V; Monfardini S
    Crit Rev Oncol Hematol; 2005 Mar; 53(3):253-65. PubMed ID: 15718150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less cancer--or more--with HAART? Or, reflections on a late opus.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1998 Jun; 4(6):12-22. PubMed ID: 11365531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
    Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus-associated neoplasms: epidemiology, pathogenesis, and review of current therapy.
    Aboulafia DM
    Cancer Pract; 1994; 2(4):297-306. PubMed ID: 7858657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
    Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
    Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-cancer agents.
    TreatmentUpdate; 1998 Jun; 10(4):1-6. PubMed ID: 11365440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
    Gabarre J; Bossi P
    Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary manifestations of acquired immunodeficiency syndrome-associated malignancies.
    Irwin DH; Kaplan LD
    Semin Respir Infect; 1993 Jun; 8(2):139-48. PubMed ID: 8278681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
    Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
    J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
    Dezube BJ
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.